Lilly collaborates with NIH to test Olumiant in patients hospitalized with COVID-19 Kumar Jeetendra | April 18, 2020 USA-based Eli Lilly has joined a huge and quickly developing rundown of drugmakers chipping away at treatments to battle COVID-19, with the consideration of Olumiant (baricitinib) in a National Institutes of Health (NIH)- supported preliminary. Olumiant will presently be incorporated as an arm in the Adaptive COVID-19 Treatment Trial. The investigation will test the item …
